Back to articles
Comparative guide · 6 min read

Fish Oil vs Algal Oil — bioequivalence, contaminants, and what the trials show

Updated 2026-05-12 · Reviewed by SupplementScore editors · No sponsorships

Fish are not the original source of EPA and DHA — microalgae are. Fish accumulate omega-3s by eating algae (or eating fish that ate algae). Algal oil cuts out the fish entirely and supplies DHA, and increasingly EPA, directly from cultivated microalgae. The bioequivalence trials are remarkably clean: blood-level rises in EPA, DHA, and the omega-3 index are equivalent between the two sources at matched doses. The decision is rarely about effect; it's about sustainability, contaminants, taste, and cost.

Quick verdict

GoalBetter choiceWhy
Raising omega-3 index / DHA blood levels Either — equivalent at matched dose Crossover trials show identical bioavailability for both DHA and EPA.
Cost per gram of EPA/DHA Fish oil Mature supply chain makes fish oil 30–70% cheaper per gram of combined EPA/DHA.
Vegan / vegetarian / dietary restriction Algal oil The only animal-free EPA/DHA source. ALA from flax does not convert efficiently.
Heavy-metal and PCB load avoidance Algal oil Closed-system fermentation has near-zero environmental contaminant load.
Marine sustainability concerns Algal oil No wild-fish demand; lower trophic-chain footprint.
Fishy reflux / aftertaste Algal oil (slight edge) Algal oil tends to have less fishy "burp-back," particularly the high-DHA-only forms.
High-dose EPA for cardiovascular indications (≥2 g EPA/day) Fish oil (cost) or EPA-rich algal EPA-dominant fish oil is the cheapest path; high-EPA algal options exist but cost more.

How they compare on what matters

Bioequivalence — the trials are clean

Arterburn 2008 randomised adults to algal DHA (200 mg or 600 mg/day) vs cooked salmon (matched DHA dose) for 2 weeks and found equivalent rises in plasma and red-blood-cell DHA. Several subsequent trials in vegetarians, athletes, and pregnant populations have replicated the finding: matched dose → matched omega-3 index rise. The "fish-derived omega-3 is more bioavailable" claim is not supported by the bioequivalence literature. The dose is what matters.

EPA and DHA content — the real differentiator

Fish oil ratios are species-dependent. Standard fish oil softgels (anchovy/sardine blend) typically run ~180 mg EPA + 120 mg DHA per 1000 mg gel. EPA-rich preparations (esterified concentrates) reach 800–1000 mg EPA per gel. Cod liver oil is lower EPA/DHA and higher A/D. Krill oil is lower EPA/DHA per pill but phospholipid-bound (incremental absorption advantage, contested).

Algal oil ratios depend on the strain used. Schizochytrium oils are DHA-dominant — often 400–500 mg DHA with 200 mg EPA per softgel. Crypthecodinium oils are nearly pure DHA. EPA-rich algal preparations from Phaeodactylum and other strains are emerging but still cost-premium vs fish-derived EPA. For DHA-dominant needs (cognition, pregnancy, infant development), algal oil is functionally equivalent and often more concentrated. For EPA-dominant indications (cardiovascular, depression, inflammation), fish oil currently has the cleaner EPA economics.

Contaminants — fish oil's worst structural problem

Wild fish accumulate methylmercury, dioxins, PCBs, and polybrominated flame retardants through bioaccumulation. The processing of fish oil (molecular distillation, supercritical CO2 extraction) substantially reduces contaminant load, but well-tested batches still vary widely. Independent batch testing (IFOS, Friend of the Sea, third-party COAs) shows that "premium" brands typically meet stringent limits but mid-market brands often do not. Algal oil produced in fermentation tanks has near-zero environmental contaminant exposure by design — the contaminant question is essentially solved.

Oxidation — the freshness problem both share

Both fish and algal oils oxidise. Oxidised fish/algal oil tastes bad, smells "fishy," and may produce reactive aldehydes that some research suggests are pro-inflammatory rather than anti-inflammatory. Look for oxidation markers on the COA: peroxide value (PV) under 5 meq/kg, anisidine value (AV) under 20, total oxidation (TOTOX) under 26. Refrigerate liquid forms; consume soft gels well within their best-before window. Algal oil oxidises similarly to fish oil but tends to have less "off" taste at moderate oxidation states.

Sustainability and ethics

Fish-oil supply has measurable impact on marine populations — anchovy and sardine fisheries supply most of the omega-3 market. Stocks vary in management quality; the Marine Stewardship Council certification is one signal of sustainable sourcing. Algal oil has a fundamentally lower trophic-chain footprint and zero wild-fish demand. For consumers prioritising sustainability, algal oil is the cleaner option on this dimension.

Practical rule. Choose fish oil for cost efficiency at higher EPA doses (e.g., 1.8–4 g/day for triglyceride lowering) and pick a third-party-tested brand. Choose algal oil if you're vegan or vegetarian, if you prioritise contaminant-free supply, if you're targeting DHA-dominant outcomes (pregnancy, infant brain development), or if you find fish oil unpalatable. The clinical effect at matched dose is the same — pick on practical fit.

Dose and form

General cardiovascular maintenance: 1–2 g/day EPA+DHA combined. Triglyceride lowering: 2–4 g/day EPA+DHA. Pregnancy / infant brain development: 200–300 mg DHA/day minimum. Depression adjunct: 1–2 g/day EPA-dominant. For fish oil: triglyceride form (TG) and re-esterified triglyceride (rTG) appear marginally better absorbed than ethyl ester (EE) form, though the absorption difference shrinks when taken with a fatty meal. For algal oil: TG form is standard and well-absorbed. Always take with a meal containing fat.

Safety and what to skip

Mild GI symptoms and "fishy burp-back" are the most common adverse effects of both. Theoretical antiplatelet effect is real but clinically modest at typical supplemental doses (1–2 g/day); becomes relevant at pharmacological doses (4+ g/day) — discuss with prescriber if on anticoagulants. The 2024 atrial-fibrillation signal from RCTs at pharmacological doses (1.8–4 g/day) merits discussion with a cardiologist before high-dose use, particularly in users with arrhythmia history. Avoid "omega-3-6-9 blends" — most people get adequate omega-6 already and bundling adds cost without benefit. Avoid "raw fish oil" without distillation — contamination risk is meaningful.

What the price difference buys you

Fish oil runs $0.08–0.20 per gram of combined EPA+DHA at mid-market prices. Algal oil runs $0.30–0.60 per gram of combined EPA+DHA — typically 3–5× more expensive. The premium reflects the smaller-scale fermentation production rather than any clinical superiority. For high-EPA cardiovascular dosing, the cost gap matters; for general maintenance dosing, the absolute monthly cost difference is $5–15.

Who should pick each

Pick fish oil if: cost is a priority, you tolerate fish-derived products, you've chosen a third-party-tested brand with verified low contaminant load, you need ≥2 g/day EPA for triglyceride or other indications.

Pick algal oil if: you're vegan/vegetarian or avoid fish, you prioritise contaminant-free supply, you're pregnant or breastfeeding (DHA is the relevant target and algal DHA is widely supported), you have an allergy or strong aversion to fish-derived products, you have marine-sustainability concerns.

Sources

Read more: